442 related articles for article (PubMed ID: 15163541)
21. C3b receptor (CR1) expression on the polymorphonuclear leukocytes from patients with systemic lupus erythematosus.
Fyfe A; Holme ER; Zoma A; Whaley K
Clin Exp Immunol; 1987 Feb; 67(2):300-8. PubMed ID: 2955969
[TBL] [Abstract][Full Text] [Related]
22. Increased expression of soluble inducible costimulator ligand (ICOSL) in patients with systemic lupus erythematosus.
Her M; Kim D; Oh M; Jeong H; Choi I
Lupus; 2009 May; 18(6):501-7. PubMed ID: 19395451
[TBL] [Abstract][Full Text] [Related]
23. Expression profile of HIN200 in leukocytes and renal biopsy of SLE patients by real-time RT-PCR.
Kimkong I; Avihingsanon Y; Hirankarn N
Lupus; 2009 Oct; 18(12):1066-72. PubMed ID: 19762380
[TBL] [Abstract][Full Text] [Related]
24. Decreased C3b receptors (CR1) on erythrocytes from patients with systemic lupus erythematosus.
Holme E; Fyfe A; Zoma A; Veitch J; Hunter J; Whaley K
Clin Exp Immunol; 1986 Jan; 63(1):41-8. PubMed ID: 2937582
[TBL] [Abstract][Full Text] [Related]
25. Family studies of erythrocyte complement receptor type 1 levels: reduced levels in patients with SLE are acquired, not inherited.
Walport MJ; Ross GD; Mackworth-Young C; Watson JV; Hogg N; Lachmann PJ
Clin Exp Immunol; 1985 Mar; 59(3):547-54. PubMed ID: 3987091
[TBL] [Abstract][Full Text] [Related]
26. [Small increase of CR1 and CR3 by C5a-receptors on polymorphonuclear leukocytes in systemic lupus erythematosus].
Doi T; Takemura S; Onodera H; Ueda M; Deguchi M; Nakahara R; Ichio N; Nakanishi S; Seto N; Yanagida K; Kondo M
Arerugi; 1997 Nov; 46(11):1108-13. PubMed ID: 9436327
[TBL] [Abstract][Full Text] [Related]
27. Association of complement receptor 1 (CR1, CD35, C3b/C4b receptor) density polymorphism with glomerulonephritis in Indian subjects.
Katyal M; Tiwari SC; Kumar A; Dinda AK; Arora V; Kumar R; Das N
Mol Immunol; 2004 Apr; 40(18):1325-32. PubMed ID: 15072851
[TBL] [Abstract][Full Text] [Related]
28. The rate of loss of CR1 from ageing erythrocytes in vivo in normal subjects and SLE patients: no correlation with structural or numerical polymorphisms.
Moldenhauer F; Botto M; Walport MJ
Clin Exp Immunol; 1988 Apr; 72(1):74-8. PubMed ID: 2899464
[TBL] [Abstract][Full Text] [Related]
29. Erythrocytes transfused into patients with SLE and haemolytic anaemia lose complement receptor type 1 from their cell surface.
Walport M; Ng YC; Lachmann PJ
Clin Exp Immunol; 1987 Sep; 69(3):501-7. PubMed ID: 2959411
[TBL] [Abstract][Full Text] [Related]
30. Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestations.
Yajima N; Kasama T; Isozaki T; Odai T; Matsunawa M; Negishi M; Ide H; Kameoka Y; Hirohata S; Adachi M
Arthritis Rheum; 2005 Jun; 52(6):1670-5. PubMed ID: 15934075
[TBL] [Abstract][Full Text] [Related]
31. Up-regulation of TRAIL mRNA expression in peripheral blood mononuclear cells from patients with active systemic lupus erythematosus.
Komatsuda A; Wakui H; Iwamoto K; Togashi M; Maki N; Masai R; Hatakeyama T; Sawada K
Clin Immunol; 2007 Oct; 125(1):26-9. PubMed ID: 17683987
[TBL] [Abstract][Full Text] [Related]
32. Expression and significance of leukocyte membrane cofactor protein transcript in systemic lupus erythematosus.
Biswas B; Kumar U; Das N
Lupus; 2012 Apr; 21(5):517-25. PubMed ID: 22247341
[TBL] [Abstract][Full Text] [Related]
33. Quantification of the complement receptor function on polymorphonuclear leukocytes: its significance in patients with systemic lupus erythematosus.
Yoshida K; Yukiyama Y; Miyamoto T
J Rheumatol; 1987 Jun; 14(3):490-6. PubMed ID: 3498035
[TBL] [Abstract][Full Text] [Related]
34. Complement-mediated solubilization of immune complexes in systemic lupus erythematosus.
Sakurai T; Fujita T; Kono I; Kabashima T; Yamane K; Tamura N; Kashiwagi H
Clin Exp Immunol; 1982 Apr; 48(1):37-42. PubMed ID: 6979449
[TBL] [Abstract][Full Text] [Related]
35. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
[TBL] [Abstract][Full Text] [Related]
36. Physiological up-regulation of inhibitory receptors Fc gamma RII and CR1 on memory B cells is lacking in SLE patients.
Isaák A; Gergely P; Szekeres Z; Prechl J; Poór G; Erdei A; Gergely J
Int Immunol; 2008 Feb; 20(2):185-92. PubMed ID: 18182380
[TBL] [Abstract][Full Text] [Related]
37. Down-regulation of TIPE2 mRNA expression in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
Li D; Song L; Fan Y; Li X; Li Y; Chen J; Zhu F; Guo C; Shi Y; Zhang L
Clin Immunol; 2009 Dec; 133(3):422-7. PubMed ID: 19748832
[TBL] [Abstract][Full Text] [Related]
38. A lysine-binding protein in SLE sera inhibits the binding of immune complexes to normal erythrocyte CR1 (complement receptor type 1).
Ng YC; Peters DK; Cederholm-Williams SA; Walport MJ
Clin Exp Immunol; 1987 Jul; 69(1):89-97. PubMed ID: 3115654
[TBL] [Abstract][Full Text] [Related]
39. The human C3b receptor (CR1).
Weiss L; Fischer E; Haeffner-Cavaillon N; Jouvin MH; Appay MD; Bariety J; Kazatchkine M
Adv Nephrol Necker Hosp; 1989; 18():249-69. PubMed ID: 2522267
[TBL] [Abstract][Full Text] [Related]
40. Complement receptor 1 (CD35) on human reticulocytes: normal expression in systemic lupus erythematosus and HIV-infected patients.
Lach-Trifilieff E; Marfurt J; Schwarz S; Sadallah S; Schifferli JA
J Immunol; 1999 Jun; 162(12):7549-54. PubMed ID: 10358211
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
